Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03855475
Other study ID # 1256861
Secondary ID R01AG058853
Status Completed
Phase N/A
First received
Last updated
Start date March 1, 2019
Est. completion date March 31, 2024

Study information

Verified date May 2024
Source University of Delaware
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will measure brain structure through its mechanical properties, assessed with magnetic resonance elastography, and determine whether it improves with aerobic exercise in older adults with low memory abilities. Additionally, this study will determine if memory abilities improve with exercise and if they are related to brain structure. Overall, this project has the potential to identify how brain health is impacted by exercise in older adults.


Description:

Mechanical properties of the human brain, measured with magnetic resonance elastography (MRE), reflect the health of brain tissue. Our previous research has shown that these mechanical properties of the hippocampus are highly sensitive to memory function in young adults. Based on these findings, we believe that these mechanical properties may be strong indicators of memory health in older adults and populations experiencing decline in memory function (i.e. mild cognitive impairment, MCI). Further, our results indicate these properties and associated functions are positively impacted by fitness and exercise training, thus making them potentially ideal markers for brain health in assessing rehabilitation. The objective of this research is to examine these properties in older adults with and without MCI. We will do the following: (1) determine if there are differences in mechanical properties of memory systems in older adults with and without MCI; (2) establish structure-function relationships between mechanical properties and memory performance in the older adult population; and (3) determine if both mechanical properties and memory performance are impacted by cardiovascular health, both through cross-sectional assessment of aerobic fitness and longitudinal response to exercise training.


Recruitment information / eligibility

Status Completed
Enrollment 36
Est. completion date March 31, 2024
Est. primary completion date December 31, 2023
Accepts healthy volunteers No
Gender All
Age group 60 Years to 90 Years
Eligibility Inclusion Criteria: - Cognitive function scores consistent with amnestic mild cognitive impairment based on pre-screening evaluation - age 60-90 years - MMSE score >24 at time of initial consent Exclusion Criteria: - major psychiatric disorder (e.g. schizophrenia, bipolar disorder, major depression within past two years) - neurological or autoimmune conditions affecting cognition (e.g. Parkinson's disease, epilepsy, multiple sclerosis, head trauma with loss of consciousness greater than 30 min, large vessel infarct) - other systemic medical illnesses (e.g. cardiovascular disease, cancer, renal failure, diabetes, chronic obstructive pulmonary disease, liver diseases, hypertension) - current medication use likely to affect CNS functions (e.g. long active benzodiazepines) - failed outcome on the baseline graded exercise test - hypertension (systolic 130+ mmHg OR diastolic 80+ mmHg) from baseline blood pressure measurement - claustrophobia, metal implants, pacemaker or other factors affecting feasibility and/or safety of MRI scanning - concussion within last 2 years and more than 3 lifetime concussions - current smoking (including marijuana) within the past 3 months

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Aerobic exercise
Participants will complete 12 weeks of supervised aerobic exercise, 3 times per week, on a treadmill or stationary bicycle
Stretching
Participants will complete 12 weeks of supervised stretching, 3 times per week

Locations

Country Name City State
United States University of Delaware Newark Delaware

Sponsors (4)

Lead Sponsor Collaborator
University of Delaware Christiana Care Health Services, National Institute on Aging (NIA), University of Illinois at Urbana-Champaign

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other Change in brain morphometry MRI will be used to measure brain morphometry, i.e. volume Baseline, 12 weeks
Other Change in brain function MRI will be used to measure brain function, i.e. functional connectivity Baseline, 12 weeks
Other Change in brain white matter integrity Diffusion MRI will be used to measure integrity of white matter tracts Baseline, 12 weeks
Other Change in cognitive function NIH Toolbox will be used to assess cognitive function across several domains Baseline, 12 weeks
Primary Change in brain mechanical properties Investigators are assessing change in brain structure through mechanical properties in response to exercise from baseline to the end of the 12 week program. An MRI scan with magnetic resonance elastography (MRE) will be used to measure properties of brain regions important to memory (e.g. hippocampus). Baseline, 12 weeks
Secondary Change in relational memory performance Behavioral memory test will be used to assess relational memory through accuracy on a spatial reconstruction task. Baseline, 12 weeks
Secondary Change in cardiorespiratory fitness Graded exercise test will measure cardiorespiratory fitness through volume of oxygen uptake (VO2) Baseline, 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT04513106 - Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial N/A
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Active, not recruiting NCT03167840 - Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment N/A
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Not yet recruiting NCT05041790 - A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment Phase 4
Recruiting NCT04121156 - High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Completed NCT02774083 - Cognitive Training Using Feuerstein Instrumental Enrichment N/A
Completed NCT01315639 - New Biomarker for Alzheimer's Disease Diagnostic N/A
Enrolling by invitation NCT06023446 - Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
Completed NCT04567745 - Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers Phase 1
Recruiting NCT05579236 - Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Terminated NCT02503501 - Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease Phase 2
Not yet recruiting NCT03740178 - Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) Phase 1
Active, not recruiting NCT05204940 - Longitudinal Observational Biomarker Study
Recruiting NCT02663531 - Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Recruiting NCT03507192 - Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia. N/A